AU2002218022A1 - Plasmid vectors - Google Patents

Plasmid vectors

Info

Publication number
AU2002218022A1
AU2002218022A1 AU2002218022A AU1802202A AU2002218022A1 AU 2002218022 A1 AU2002218022 A1 AU 2002218022A1 AU 2002218022 A AU2002218022 A AU 2002218022A AU 1802202 A AU1802202 A AU 1802202A AU 2002218022 A1 AU2002218022 A1 AU 2002218022A1
Authority
AU
Australia
Prior art keywords
plasmid vectors
plasmid
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002218022A
Other languages
English (en)
Inventor
Shana Barbas-Frederickson
Katherine S. Bowdish
John Mcwhirter
Martha Wild
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alexion Pharmaceuticals Inc
Original Assignee
Alexion Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharmaceuticals Inc filed Critical Alexion Pharmaceuticals Inc
Publication of AU2002218022A1 publication Critical patent/AU2002218022A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/72Expression systems using regulatory sequences derived from the lac-operon

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002218022A 2000-12-08 2001-12-07 Plasmid vectors Abandoned AU2002218022A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25441100P 2000-12-08 2000-12-08
US60/254,411 2000-12-08
PCT/US2001/046516 WO2002046436A2 (fr) 2000-12-08 2001-12-07 Nouveaux vecteurs plasmidiques

Publications (1)

Publication Number Publication Date
AU2002218022A1 true AU2002218022A1 (en) 2002-06-18

Family

ID=22964211

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002218022A Abandoned AU2002218022A1 (en) 2000-12-08 2001-12-07 Plasmid vectors

Country Status (2)

Country Link
AU (1) AU2002218022A1 (fr)
WO (1) WO2002046436A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435126D1 (de) * 1993-10-19 2008-10-02 Scripps Research Inst Synthetische humane neutralisierende monoklonale antikörper gegen hiv
AU2002226049A1 (en) * 2000-12-05 2002-06-18 Alexion Pharmaceuticals, Inc. Engineered plasmids and their use for in situ production of genes

Also Published As

Publication number Publication date
WO2002046436A3 (fr) 2003-03-06
WO2002046436A2 (fr) 2002-06-13
WO2002046436A9 (fr) 2003-04-17

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001258349A1 (en) Bisacylguanidine
AU2001232054A1 (en) Vector
AU2001245494A1 (en) Flexible laminations
AU2001258924A1 (en) Microsatellite-aflp
AU2001240791A1 (en) Sequence
AU2001242625A1 (en) Gene sequence
AU2001240103A1 (en) Reproduction-specific genes
AU2001246864A1 (en) Hypotensors
AU2001288839A1 (en) Self-rearranging dna vectors
AU4672401A (en) Vectors
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001260192A1 (en) Glycinamides
AU2002225914A1 (en) Plasmid vectors
AU2001275014A1 (en) Imidazoloisoquinolines
AU2001251324A1 (en) An endogenous ketogulonigenium plasmid
AU2002218022A1 (en) Plasmid vectors
AU2002211324A1 (en) Oxidoreductases
AU2001212995A1 (en) Improved spectacles
AU2001256521A1 (en) Golf-putters